LLY Today - Jul 11: Mixed signals on growth

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

LLY Today - Jul 11: Mixed signals on growth

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly neighborhood investor. Today, we’re breaking down Eli Lilly, and spoiler alert: it was a red day. The stock dipped about 2.3%. Ouch!

So, what went down? Well, LLY got smoked today, losing some ground after a pretty mixed bag of news. It opened strong but then drifted down as the day went on. People were hitting that sell button pretty fast, which isn’t the best sign.

Now, why the drop? There’s chatter about Eli Lilly's premium valuation. Some folks are wondering if it’s really justified given the current growth story. Yeah, that one stung. They’ve got some new data coming out for their Kisunla treatment and an Alzheimer’s blood test, but it seems like investors are a bit skeptical. Plus, their new Foundayo launch hasn’t exactly been setting the world on fire. It’s been described as “muted,” which doesn’t sound too exciting, right?

On the horizon, they’re gearing up to share that new data at the Alzheimer’s Association International Conference. So, that could shake things up a bit, depending on how it goes.

To wrap it up, today wasn’t Eli Lilly’s best day. With some mixed signals on growth and a bit of investor hesitation, it’s clear why the stock took a hit. Just remember, this is all for fun and info, not financial advice. Catch you later!

まだレビューはありません